• Home
  • » 
  • Reports
  • » 
  • Modular Manufacturing Market | Industry Analysis | Market Size | 2035

Modular Manufacturing Market

Modular Facilities in Pharmaceutical and Biotechnology Market - Distribution by Size of Facility (Small, Mid-sized, Large and Very Large), Type of Industry Served (Pharmaceutical and Biotechnology), Type of Modular Construct (Hybrid Skid Modular Constructs, Skid-Mounted Modular Constructs, Plug-and-Play Modular Constructs, Truckable Modular Constructs and Other Modular Constructs), Type of Construction Component (Process Equipment, Base Building, Mechanical, Electrical and Plumbing System, Process Commodities and Other Construction Components), Purpose of Facility (Manufacturing Facilities, Aseptic Filling Facilities, Research and Development Facilities and Other Facilities), Scale of Operation (Clinical and Commercial), Type of Product (Cell and Gene Therapies, Vaccines, Biosimilars, Monoclonal Antibodies, Advanced Pharmaceuticals, Sterile Products, Viral Vectors and Other Products), Type of Facility (New Facilities, Facility Expansions and Planned Expansions), Type of Modular Construction (Relocatable Modular Construction, Permanent Modular Construction), Type of Material Used (Steel, Wood and Concrete) and Key Geographical Regions (North America, Europe, Asia, Middle East and North Africa, and Rest of the World): Industry Trends and Global Forecasts, 2023-2035

  • Lowest Price Guaranteed From USD 5,899

  • Published
    February 2023

  • Pages
    387

  • View Count
    32213

  • Buy Now

Example Insights

Modular-Facilities-in-Pharmaceutical-and-Biotechnology-Market-Context-thumb Modular-Facilities-in-Pharmaceutical-and-Biotechnology-Market-List-of-Providers-thumb Modular-Facilities-in-Pharmaceutical-and-Biotechnology-Market-Historical-and-Current-Trend-Analysis-thumb
Modular-Facilities-in-Pharmaceutical-and-Biotechnology-Market-Cleanroom-Providers-thumb Modular-Facilities-in-Pharmaceutical-and-Biotechnology-Market-Competitiveness-Analysis-thumb Modular-Facilities-in-Pharmaceutical-and-Biotechnology-Market-Partnerships-and-Collaborations-thumb
Modular-Facilities-in-Pharmaceutical-and-Biotechnology-Market-Distribution-by-Size-of-Facility-thumb Modular-Facilities-in-Pharmaceutical-and-Biotechnology-Market-Future-Growth-Opportunities-thumb Modular-Facilities-in-Pharmaceutical-and-Biotechnology-Market-Likely-Growth-Scenarios-thumb
Modular-Facilities-in-Pharmaceutical-and-Biotechnology-Market-Distribution-by-Scale-of-Operation-thumb Modular-Facilities-in-Pharmaceutical-and-Biotechnology-Market-Distribution-by-Type-of-Construction-Component-thumb Modular-Facilities-in-Pharmaceutical-and-Biotechnology-Market-Forecast-thumb

Report Description

In terms of internal rate of return (IRR), modular manufacturing facilities are less expensive than stick-built facilities, with an IRR of 11% versus 8% for stick-built facilities. This provides an excellent opportunity for business partners to optimize project costs

-- CEO, a US-based mid-sized company

In the past few years, modular facilities or prefabricated buildings have emerged as a promising alternative to the conventionally built pharma / biotech manufacturing facilities. Modular construction involves building of structures using prefabricated modular units, off-site, under controlled factory setting, which are later assembled on site.  It is interesting to note that off-site construction can eliminate 60%-90% of the weather-related project concerns.  Further, modular facilities can be built 40% faster, as compared to a conventional construction, which could take up to three years.  Therefore, considering the various advantages offered by this approach, several pharmaceutical players are now shifting their focus from conventional plants to modular facilities. Specifically, modular facility providers are catering to the needs of various players engaged in the development of therapeutics, including cell and gene therapy, biosimilars and vaccines. To provide more context, modular biomanufacturing includes division of individual production processes, such as fermentation, purification and formulation, into separate modules that can be easily assembled and disassembled, allowing for flexibility and scalability.  In addition, modular manufacturing allows the use of smaller-scale production units, which can be more flexible and responsive to dynamic market demands.  Moreover, temporary modular buildings can be relocated after installation, based on needs of the end-user. However, mass production, complex decision-making, construction approvals and early financing can hinder the adoption of modular constructs. If healthcare stakeholders are able to overcome these challenges, modular construction can serve as a lucrative approach that provides greater flexibility and enables faster time-to-market for new products. 

Key Market Insights

The Modular Manufacturing Facilities Market in Pharmaceutical and Biotechnology (3rd Edition) - Distribution by Size of Facility (Small, Mid-sized, Large and Very Large), Type of Industry Served (Pharmaceutical and Biotechnology), Type of Modular Construct (Hybrid Skid Modular Constructs, Skid-Mounted Modular Constructs, Plug-and-Play Modular Constructs, Truckable Modular Constructs and Other Modular Constructs), Type of Construction Component (Process Equipment, Base Building, Mechanical, Electrical and Plumbing System, Process Commodities and Other Construction Components), Purpose of Facility (Manufacturing Facilities, Aseptic Filling Facilities, Research and Development Facilities and Other Facilities), Scale of Operation (Clinical and Commercial), Type of Product (Cell and Gene Therapies, Vaccines, Biosimilars, Monoclonal Antibodies, Advanced Pharmaceuticals, Sterile Products, Viral Vectors and Other Products), Type of Facility (New Facilities, Facility Expansions and Planned Expansions), Type of Modular Construction (Relocatable Modular Construction, Permanent Modular Construction), Type of Material Used (Steel, Wood and Concrete) and Key Geographical Regions (North America, Europe, Asia, Middle East and North Africa, and Rest of the World): Industry Trends and Global Forecasts, 2023-2035 report features an extensive study of the current market landscape and future opportunity, offering an informed opinion on the likely adoption of modular facilities in the pharmaceutical and biotechnology industries, over the next 12 years. The report features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. The report answers the following key questions related to this domain.

Key Advantages Offered by Modular Facilities

Modular manufacturing facilities have emerged as a promising alternative to conventional facilities owing to the multiple benefits that they offer. For instance, modular facilities can help in achieving 25%-30% reduction in the overall cost of construction, minimal plant site interruption, 50%-60% faster construction timelines, as well as ensure portability, safe working conditions and sustainability. In addition, better quality of products can be achieved by modular construction approaches owing to the fact that modules are built in a controlled factory setting. In addition, these modules are inspected more thoroughly and frequently before they are shipped to the construction site meeting desired quality standards. Moreover, modular construction allows more flexibility in terms of design, as a higher number of materials and finishes can be used, as compared to conventional facilities.

Current Market Landscape of Modular Manufacturing Facilities

The modular facilities market landscape features an extensive list of over 50 large, mid-sized, small and very small players. It is worth highlighting that more than 250 players are engaged in offering modular cleanrooms, along with various cleanroom accessories and customization options, in order to make them suitable for application in the life sciences industry. It is expected that modular facilities will become more streamlined and standardized in the future, serving as an efficient cost saving solution. Additionally, modular techniques allow building of smaller and  specialized processing plants whenever rapid deployment of a therapy becomes critical in both developed and developing countries. Further, many, if not most, expansions and new facilities in the pharmaceutical and biotechnology industry are likely to be modular constructions in the near future.

Key Drivers in the Modular Facilities Market

Over the past few years, several factors have contributed to reform the facility construction paradigm within the pharmaceutical and biotechnology industries. The increasing preference and demand for personalized therapies and novel therapeutic interventions intended for the treatment of various ailments has compelled pharmaceutical companies to look beyond the traditional manufacturing and expansion practices. Lack of adequate manufacturing infrastructure, increased cost of construction and delay in project deliveries has collectively contributed to the emergence of off-site construction models.

Overall Size of Modular Facilities Market

Driven by the rising interest of stakeholders towards improvement of manufacturing and production efficiency, the anticipated lucrative opportunities and growth associated with adoption of modular manufacturing facilities, this market is expected to witness noteworthy growth in the foreseen future. Specifically, in terms of type of product, the market is anticipated to be driven by manufacturing units for cell and gene therapies, as well as vaccines and biosimilars. In addition, presently, close to 70% of the market share is captured by players based in North America and Europe. However, in the long run, markets in emerging regions, such as countries based in Asia, MENA and rest of the world are anticipated to grow at a faster pace.

Leading Players in the Modular Facilities Market

Examples of players engaged in this domain (which have also been profiled in this report) include (in alphabetical order) Cytiva, G-CON Manufacturing, Germfree, IPM Technologies, KeyPlants, ModuleCo Pharma, NNE and Pharmadule.

Scope of the Report

The study presents an in-depth analysis of the various firms / organizations that are engaged in this domain, across different segments as defined in the below table:
 

Report Attribute Details

Forecast Period

2023 – 2035

Size of Facility

Small, Mid-sized, Large and Very Large

Type of Construction Component

 Process Equipment, Base Building, Mechanical, Electrical and Plumbing System, Process Commodities and Other Construction Components

Type of Facility

 Manufacturing Facilities, Aseptic Filling Facilities, Research and Development Facilities, and Other Facilities

Scale of Operation

Clinical and Commercial

Type of Industry Served

 Pharmaceutical and Biotechnology
Type of Product Cell and Gene Therapies, Vaccines, Biosimilars, Monoclonal Antibodies, Advanced Pharmaceuticals, Sterile Products, Viral Vectors and Other Products
Type of Facility New Facilities, Facility Expansions and Planned Expansions
Type of Modular Construction Permanent and Relocatable
Type of Material Used Steel, Wood and Concrete
Key Geographical Regions North America, Europe, Asia-Pacific, MENA and Rest of the World
Customization Scope 15% Free Customization Option
PowerPoint Presentation (Complimentary) Available
Excel Data Packs (Complimentary) Market Landscape Analysis, Modular Cleanroom Providers Analysis, Company Competitiveness Analysis, Partnership and Collaboration Analysis, Case Study on Modular projects Analysis, Facility Construction Trends Analysis and Market Forecast and Opportunity Analysis

The report features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. Amongst other elements, the report includes:

  • An executive summary of the key insights captured during our research, offering a high-level view on the current state of the modular facilities market and its likely evolution in the short to mid and long term.
  • A brief introduction to important concepts related to modular facilities, featuring information on different types of modular constructs, as well as primary applications of modular facilities in the pharmaceutical and biotechnology domains. Further, this chapter highlights the recent advancements that have been reported in this market space.
  • A detailed assessment of the current market landscape of modular facilities, highlighting the contributions of various service providers, along with information on their year of establishment, company size (small, mid-sized and large), location of headquarters (North America, Europe, Asia and rest of the world), type of industry served (pharmaceutical, biotechnology), geographical coverage (North America, Europe, Asia and rest of the world), GMP compliance, type of modular construction (relocatable, permanent), type of material used (steel, wood and concrete) and quality certification(s) obtained.
  • A detailed review of the overall landscape of the modular cleanroom providers market, highlighting the contributions of various players, along with information on their year of establishment, company size (small, mid-sized and large) , location of headquarters (North America, Europe, Asia, MENA and rest of the world), type of industry served (pharmaceutical, biotechnology), type of modular cleanroom offered (hardwall, softwall and unspecified), type of cleanroom component offered (air handling units, HEPA filters, ULPA filters, laminar air flow units, air showers, pass throughs, biosafety cabinets, cleanroom furniture, plumbing / piping, lighting / electrical, doors and windows) and quality certification(s) obtained.
  • An in-depth company competitiveness analysis of modular facility service providers, segmented into three categories, namely small (2-50 employees), mid-sized (51-500 employees) and large (>500 employees) players. Within the respective peer groups, companies were ranked based on various relevant parameters, such as service strength (based on the years of experience), company competitiveness (based on parameters, such as type of industry served, GMP compliance, type of modular construction and type of material), as well as partnership activity (in terms of number of partnerships and type of agreements).
  • Elaborate profiles of prominent players that are currently engaged in offering modular facilities. Each profile features a brief overview of the company (with information on year of establishment, number of employees, location of headquarters and key members of the executive team), details related to their respective service portfolio, recent developments and an informed future outlook.
  • An analysis of the partnerships inked between various stakeholders in this domain, during the period 2012-2022, featuring a detailed set of analyses based on various parameters, such as year of partnership, type of partnership, type of product, type of modular facility, location of modular facility, geographical location of the companies involved and most active players.
  • A detailed case study on modular projects undertaken by modular facility manufacturers in the pharmaceutical and biotechnology industry, along with information on type of modular facility, size of modular facility, number of projects delivered and location of modular facility.
  • An insightful analysis on facility construction trends observed in the pharmaceutical industry over the last seven years, highlighting facility construction projects established by top 20 pharma / biotech players, along with the information on number of facilities, type of facility, purpose of facility, investments made in modular projects, size of facility and location of headquarters.
  • An insightful framework that enables a thorough examination of the cost and time related benefits offered by the use of different modular approaches, by considering multiple parameters, including long-term benefits and sustainability, to identify the most appropriate solution for various types of end users and enabling them to make informed decisions.
  • A detailed market forecast analysis to estimate the existing market size and the future opportunity for modular facility manufacturers, till 2035; the overall opportunity has been distributed across various segments, such as size of facility (small, mid-sized, large and very large), type of industry served (pharmaceutical and biotechnology), type of modular construct (hybrid skid modular constructs, skid-mounted modular constructs, plug-and-play modular constructs, truckable modular constructs and other modular constructs), type of construction component (process equipment, base building, mechanical, electrical and plumbing system, process commodities and other construction components), purpose of facility (manufacturing facilities, aseptic filling facilities, research and development facilities and other facilities), scale of operation (clinical and commercial), type of product (cell and gene therapies, vaccines, biosimilars, monoclonal antibodies, advanced pharmaceuticals, sterile products, viral vectors and other products), type of facility (new facilities, facility expansions and planned expansions), type of modular construction (relocatable modular construction, permanent modular construction), type of material (steel, wood and concrete) and key geographical regions (North America, Europe, Asia, Middle East And North Africa, and rest of the world). In order to account for future uncertainties and to add robustness to our model, we have provided three forecast scenarios, namely conservative, base and optimistic scenarios, representing different tracks of the industry’s growth.
  • A review of emerging industry trends, including the combination of single-use technologies / continuous processing technologies with modular facilities, the shift to using smaller, multi-purpose modular facilities, and technological advancements in modular construction processes.
  • A detailed discussion on the various growth drivers, such as development of personalized medicines, biosimilars, orphan drugs and anticipated increase in the adoption of modular solutions in the emerging markets by pharmaceutical / biopharmaceutical CMOs. 

The opinions and insights presented in the report were influenced by discussions held with senior stakeholders in the industry. The report features detailed transcripts of interviews held with the following industry stakeholders: 

  • Maik Jornitz (Chief Executive Officer, G-CON Manufacturing)
  • Pär Almhem (President, ModWave)
  • Vernon Solomon (President, Environmental Systems Corporation)
  • François Abiven (Ex-President Life Sciences and Chemicals, Exyte) 
  • Mark Koers (Executive Vice President, Sales and Marketing, Modular Devices)
  • Luca Mussati (Vice President Pharmaceutical and Biotechnology, Exyte)
  • Ward Patton (Director of Sales, Subzero Engineering)
  • Wes Temple (Director of Marketing, Vernick)
  • Sulogna Roy (Ex-Sales Manager, Zeton)
  • Alan de Zayas (Modular Building Manufacturing and Construction Team, Avon Modular)

All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD, unless otherwise specified.

Frequently Asked Questions

Question 1: What is modular manufacturing?
Answer: Modular facilities are prefabricated buildings that are built using multiple sections, often known as modules. To provide more context, modular constructs are designed, engineered and manufactured off-site, and later delivered to relevant project site for final installation. Further, integrated assemblies are joined together to create facilities of significant size, housing multiple functions and equipment.

Question 2: Which material is most widely used for the construction of modular facilities?
Answer: Steel and wood are the most commonly used materials for building pre-engineered builds. Of these, steel is usually employed to construct permanent buildings since they are built for use over longer periods of time. On the other hand, wood is generally more suitable for building relocatable constructs as the material is lightweight and hence, allows easy relocation. 

Question 3: Which types of partnerships are being inked by modular facility providers?
Answer: Full facility construction agreements, service alliances and cleanroom construction agreements are the most common partnership models adopted by stakeholders engaged in the modular facilities domain.

Question 4: Which healthcare sector is rapidly employing modular facilities?
Answers: Currently, the pharmaceutical industry is leading the adoption of modular facilities in the healthcare sector. On the other hand, the modular facilities market for biotechnology industry is expected to grow at 11%, capturing a considerable market share in the foreseen future.

Question 5: How is the modular facilities market likely to grow in the future?
Answers: The global modular facilities market is anticipated to grow at a compound annualized growth rate of 10%, till 2035.

Question 6: Which region is leading the modular facilities market?
Answers: North America and Europe, combined, hold 70% share of the global modular facilities market. In the longer run, emerging regions, such as Asia, are likely to grow at faster pace.

Contents

Table Of Contents

1. PREFACE
1.1. Introduction
1.2. Key Market Insights
1.3. Scope of the Report
1.4. Research Methodology
1.5. Frequently Asked Questions
1.6. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION 
3.1. Chapter Overview
3.2. Historical Background
3.3. The Concept of Modular Facilities
3.3.1. Types of Modular Constructs
3.3.2. Modular Construction Process

3.4. Modular Construction in the Pharmaceutical Industry
3.4.1. Advantages of Modular Construction in the Pharmaceutical Industry
3.4.2. Modular Pharmaceutical Cleanrooms
3.4.2.1. Cleanroom Classifications and Current Standards
3.4.2.2. Regulations and Standards Concerning Modular Cleanroom Construction

3.5. Advantages of Modular Cleanrooms
3.6. Challenges and Future Prospects

4. MARKET LANDSCAPE: MODULAR FACILITY MANUFACTURERS
4.1. Chapter Overview
4.2. Modular Facility Manufacturers: Overall Market Landscape
4.2.1 Analysis by Year of Establishment
4.2.2. Analysis by Company Size
4.2.3. Analysis by Location of Headquarters
4.2.4. Analysis by Year of Establishment and Location of Headquarters
4.2.5. Analysis by Company Size and Location of Headquarters
4.2.6. Analysis by Type of Industry Served
4.2.7. Analysis by Geographical Coverage
4.2.8. Analysis by Type of Industry Served and Geographical Coverage
4.2.9. Analysis by GMP Compliance
4.2.10. Analysis by Geographical Coverage and GMP Compliance
4.2.11. Analysis by Type of Modular Construction
4.2.12. Analysis by Type of Industry Served and Type of Modular Construction
4.2.13. Analysis by Type of Material Used
4.2.14. Analysis by Type of Modular Construction and Type of Material Used
4.2.15. Analysis of Historical and Current Market Landscape Trends
4.2.15.1 Analysis by Company Size, Geographical Coverage and Type of Industry Served

5. MARKET LANDSCAPE: MODULAR CLEANROOM PROVIDERS
5.1. Chapter Overview
5.2. Modular Cleanroom Providers: Overall Landscape
5.2.1. Analysis by Year of Establishment
5.2.2. Analysis by Company Size
5.2.3. Analysis by Location of Headquarters
5.2.4. Analysis by Year of Establishment and Location of Headquarters
5.2.5. Analysis by Company Size and Location of Headquarters
5.2.6. Analysis by Type of Industry Served
5.2.7. Analysis by Location of Headquarters and Type of Industry Served
5.2.8. Analysis by Type of Modular Cleanroom Offered
5.2.9. Analysis by Type of Industry Served and Type of Modular Cleanroom Offered
5.2.10. Analysis by Type of Cleanroom Component Offered
5.2.11. Analysis by Type of Industry Served and Cleanroom Component Offered
5.2.12. Analysis by Type of Modular Cleanroom and Cleanroom Component Offered
5.2.13. Analysis by Location of Headquarters, Type of Industry Served and Type of Modular Cleanroom Offered
5.2.14. Analysis by Quality Certifications Obtained

6. MODULAR FACILITY MANUFACTURERS: COMPANY COMPETITIVENESS ANALYSIS
6.1 Chapter Overview
6.2 Assumptions / Key Parameters
6.3 Methodology
6.4 Company Competitiveness Analysis: Modular Facility Manufacturers
6.4.1. Company Competitiveness Analysis: Benchmarking of Service Strength
6.4.2. Company Competitiveness Analysis: Benchmarking of Partnership activity
6.4.3. Company Competitiveness Analysis: Small Companies
6.4.4. Company Competitiveness Analysis: Mid-Sized Companies
6.4.5. Company Competitiveness Analysis: Large Companies

7. COMPANY PROFILES
7.1. Chapter Overview
7.2. Cytiva
7.2.1. Company Overview
7.2.2. Modular Facility-related Services
7.2.3. Modular Projects
7.2.4. Recent Developments and Future Outlook

7.3. G-Con Manufacturing
7.3.1. Company Overview
7.3.2. Modular Facility-related Services
7.3.3. Modular Projects 
7.3.4. Recent Developments and Future Outlook

7.4. Germfree
7.4.1. Company Overview
7.4.2. Modular Facility-related Services
7.4.3. Modular Projects 
7.4.4. Recent Developments and Future Outlook

7.5. IPM Technologies
7.5.1. Company Overview
7.5.2. Modular Facility-related Services
7.5.3. Modular Projects 
7.5.4. Recent Developments and Future Outlook

7.6. KeyPlants
7.6.1. Company Overview
7.6.2. Modular Facility-related Services
7.6.3. Modular Projects 
7.6.4. Recent Developments and Future Outlook

7.7. ModuleCo Pharma
7.7.1. Company Overview
7.7.2. Modular Facility-related Services
7.7.3. Modular Projects
7.7.4. Recent Developments and Future Outlook

7.8. NNE
7.8.1. Company Overview
7.8.2. Modular Facility-related Services
7.8.3. Modular Projects 
7.8.4. Recent Developments and Future Outlook

7.9. Pharmadule
7.9.1. Company Overview
7.9.2. Modular Facility-related Services
7.9.3. Modular Projects 
7.9.4. Recent Developments and Future Outlook

8. PARTNERSHIPS AND COLLABORATIONS
8.1. Chapter Overview
8.2. Partnership Models
8.3. Modular Facility Manufacturers: Partnerships and Collaborations
8.3.1. Analysis by Year of Partnership
8.3.2. Analysis by Type of Partnership
8.3.3. Analysis by Year of Partnership and Type of Partnership
8.3.4. Analysis by Type of Product
8.3.5. Analysis by Type of Partnership and Type of Product
8.3.6. Analysis by Type of Modular Facility
8.3.7. Analysis by Type of Product and Type of Modular Facility
8.3.8. Most Active Players: Analysis by Number of Partnerships
8.3.9. Analysis by Location of Partner’s Headquarters
8.3.10. Analysis by Location of Modular Facility
8.3.11. Analysis by Type of Partnership and Location of Modular Facility
8.3.12. Analysis by Type of Product and Location of Modular Facility
8.3.13. Intercontinental and Intracontinental Partnerships
8.3.14. Analysis by Country

9. CASE STUDY ON MODULAR PROJECTS IN PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRY
9.1. Chapter Overview
9.2. Modular Versus Conventional Construction Methods
9.3. Return on Investment
9.4. Case Study: Facility Based on KUBio Platform
9.4.1. Cytiva KUBio Platform: Overview
9.4.2. Eden Biologics Kubio Modular Project in China: Overview and Construction Details
9.5. Modular Facility Projects Undertaken in the Pharmaceutical and Biotechnology Industry
9.5.1. Analysis by Type of Modular Facility
9.5.2. Analysis by Size of Modular Facility
9.5.3. Most Active Manufacturers: Analysis by Number of Projects Delivered 
9.5.4. Leading Clients: Analysis by Number of Projects Received
9.5.5. Analysis by Location of Modular Facility
9.5.6. Analysis by Type of Facility and Size of Modular Facility
9.5.7. Analysis by Client and Location of Facility

10. FACILITY CONSTRUCTION TRENDS IN THE PHARMACEUTICAL INDUSTRY
10.1. Chapter Overview
10.2. Facility Construction Projects Undertaken in the Pharmaceutical / Biotechnology Industry: Historical Data for Top 20 Players
10.2.1. Analysis by Number of Facilities Delivered
10.2.2. Analysis by Type of Facility
10.2.3. Analysis by Purpose of Facility
10.2.4. Analysis by Type of Facility and Purpose of Facility
10.2.5. Analysis by Type of Investment
10.2.6. Analysis by Purpose of Facility and Type of Investment
10.2.7. Analysis by Size of Facility
10.2.8. Analysis by Type of Facility and Size of Facility
10.2.9. Analysis by Purpose of Facility and Size of Facility
10.2.10. Analysis by Location of Headquarters
10.2.11. Analysis by Location of Facility
10.2.12. Analysis by Type of Facility and Location of Facility

11. COST-TIME OPTIMIZATION FRAMEWORK
11.1. Chapter Overview
11.2. Key Parameters
11.3. Key Assumptions and Methodology
11.4. Comparison of Intrinsic Factors
11.4.1. Analysis by Type of Material Used
11.4.2. Analysis by Type of Modular Construction
11.4.1. Analysis by Purpose of Facility
11.4.2. Analysis by Geographical Location
11.5. Integrated Outcome Modeling – Scenario Analysis
11.6. Integrated Outcome Modeling – Output Analysis
11.7. Concluding Remarks

12. MARKET FORECAST
12.1. Chapter Overview
12.2. Forecast Methodology and Key Assumptions
12.3. Global Modular Facilities Market in the  Pharmaceutical / Biotechnology   Sector, 2023-2035

12.4. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Analysis by Size of Facility, 2023 and 2035
12.4.1. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Small Facilities, 2023-203
12.4.2. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Mid-sized Facilities, 2023-2035
12.4.3. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Large Facilities, 2023-2035
12.4.4. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Very Large Facilities, 2023-2035

12.5. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Analysis by Type of Industry Served, 2023 and 2035
12.5.1. Modular Facilities Market in the Pharmaceutical Industry, 2023-2035
12.5.2. Modular Facilities Market in the Biotechnology Industry, 2023-2035

12.6. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Analysis by Type of Modular Construct, 2023 and 2035
12.6.1. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Hybrid Skid Modular Constructs, 2023-2035
12.6.2. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Skid-Mounted Modular Constructs, 2023-2035
12.6.3. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Plug-and-Play Modular Constructs, 2023-2035
12.6.4. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Truckable Modular Constructs, 2023-2035
12.6.5. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Other Modular Constructs, 2023-2035

12.7. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Analysis by Type of Construction Component, 2023 and 2035
12.7.1. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Process Equipment, 2023-2035
12.7.2. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Base Buildings, 2023-2035
12.7.3. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Mechanical, Electrical and Plumbing Systems, 2023-2035
12.7.4. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Process Commodities, 2023-2035
12.7.5. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Other Construction Components, 2023-2035

12.8 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Analysis by Purpose of Facility, 2023 and 2035
12.8.1. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Manufacturing, 2023-2035
12.8.2. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Aseptic Filling, 2023-2035
12.8.3. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Research and Development, 2023-2035
12.8.4. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Other Purposes, 2023-2035

12.9. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Analysis by Scale of Operation, 2023 and 2035
12.9.1. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Clinical Scale, 2023-2035
12.9.2. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Commercial Scale, 2023-2035

12.10. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Analysis by Type of Product, 2023 and 2035
12.10.1. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Cell and Gene Therapies, 2023-2035
12.10.2. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Vaccines, 2023-2035
12.10.3. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Biosimilars, 2023-2035
12.10.4. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Monoclonal Antibodies, 2023-2035
12.10.5. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Advanced Pharmaceuticals, 2023-2035
12.10.6. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Sterile Products, 2023-2035
12.10.7. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Viral Vectors, 2023-2035
12.10.8. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Other Products, 2023-2035

12.11. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Analysis by Type of Facility, 2023 and 2035
12.11.1. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for New Facilities, 2023-2035
12.11.2. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Facility Expansions, 2023-2035
12.11.3. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Planned Expansions, 2023-2035

12.12. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Analysis by Type of Modular Construction, 2023 and 2035
12.12.1. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Relocatable Modular Construction, 2023-2035
12.12.2. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Permanent Modular Construction, 2023-2035

12.13. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Analysis by Type of Material Used, 2023 and 2035
12.13.1. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Steel, 2023-2035
12.13.2. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Wood, 2023-2035
12.13.3. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Concrete, 2023-2035

12.14. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Analysis by Geography, 2023 and 2035
12.14.1. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector in North America, 2023-2035
12.14.2. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector in Europe, 2023-2035
12.14.3. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector in Asia, 2023-2035
12.14.4. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector in Middle East and North Africa, 2023-2035
12.14.5. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector in Rest of the World, 2023-2035

12.15. Concluding Remarks

13. PREVALENT AND EMERGING INDUSTRY TRENDS
13.1. Chapter Overview
13.2. Adoption of Modular Facilities
13.3. Expansion of Existing Service Portfolio
13.4. Integration of Advanced Technologies
13.4.1. Single-use Technologies
13.4.2. Continuous Processing Technologies
13.4.3. Other Advanced Technologies

14. FUTURE GROWTH OPPORTUNITIES
14.1. Chapter Overview
14.2. Visibility Amongst Start-Ups
14.3. Popularity Amongst Contract Manufacturing Organizations
14.4. Expansion of Existing Facilities
14.5. Adoption for Production of Biosimilars
14.6. Additional Opportunities
14.7. Key Growth Drivers for Modular Construction
14.8. Market Attractiveness in Emerging regions

15. CONCLUSION

16. EXECUTIVE INSIGHTS
16.1. Chapter Overview
16.2. Avon Modular
16.2.1. Company Snapshot
16.2.2. Interview Transcript: Alan de Zayas (Modular Building Manufacturing and Construction Team)

16.3. Environmental Systems Corporation
16.3.1. Company Snapshot
16.3.2. Interview Transcript: Vernon Solomon (President)

16.4. Exyte
16.4.1. Company Snapshot
16.4.2. Interview Transcript: François Abiven (Executive Vice President Global Business Unit BLS) and Luca Mussati (Vice President Technology and Innovation)

16.5. G-Con Manufacturing
16.5.1. Company Snapshot
16.5.2. Interview Transcript: Maik Jornitz (Chief Executive Officer)

16.6. Modular Devices
16.6.1. Company Snapshot
16.6.2. Interview Transcript: Mark Koers (Executive Vice President, Sales and Marketing)

16.7. ModWave
16.7.1. Company Snapshot
16.7.2. Interview Transcript: Pär Almhem (President)

16.8. Subzero Engineering
16.8.1. Company Snapshot
16.8.2. Interview Transcript: Ward Patton (Director of Sales)

16.9. Vernick
16.9.1. Company Snapshot
16.9.2. Interview Transcript: Wes Temple (Director of Marketing)

16.10. Zeton
16.10.1. Company Snapshot
16.10.2. Interview Transcript: Sulogna Roy (Ex-Sales Manager)

17. APPENDIX I:  TABULATED DATA

18. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS

List Of Figures

Figure 2.1 Executive Summary: Modular Facility Manufacturers
Figure 2.2 Executive Summary: Modular Cleanroom Providers
Figure 2.3 Executive Summary: Partnerships and Collaborations
Figure 2.4 Executive Summary: Case Study on Modular Projects in Pharmaceutical and Biotechnology Industry
Figure 2.5 Executive Summary: Facility Construction Trends in the Pharmaceutical Industry
Figure 2.6 Executive Summary: Market Forecast and Opportunity Analysis
Figure 3.1 Modular Construction: Applications
Figure 3.2 Modular Construction: Processes Involved
Figure 3.3 Modular and Conventional Buildings: Construction Timeline
Figure 3.4 Modular Construction: Advantages
Figure 4.1 Modular Facility Manufacturers: Distribution by Year of Establishment
Figure 4.2 Modular Facility Manufacturers: Distribution by Company Size
Figure 4.3 Modular Facility Manufacturers: Distribution by Location of Headquarters
Figure 4.4 Modular Facility Manufacturers: Distribution by Year of Establishment and Location of Headquarters
Figure 4.5 Modular Facility Manufacturers: Distribution by Company Size and Location of Headquarters
Figure 4.6 Modular Facility Manufacturers: Distribution by Type of Industry Served
Figure 4.7 Modular Facility Manufacturers: Distribution by Geographical Coverage
Figure 4.8 Modular Facility Manufacturers: Distribution by Type of Industry Served and Geographical Coverage
Figure 4.9 Modular Facility Manufacturers: Distribution by GMP Compliance
Figure 4.10 Modular Facility Manufacturers: Distribution by Geographical Coverage and GMP Compliance
Figure 4.11 Modular Facility Manufacturers: Distribution by Type of Modular Construction
Figure 4.12 Modular Facility Manufacturers: Distribution by Type of Industry Served and Type of Modular Construction
Figure 4.13 Modular Facility Manufacturers: Distribution by Type of Material Used
Figure 4.14 Modular Facility Manufacturers: Distribution by Type of Modular Construction and Type of Material Used
Figure 4.15 Modular Facility Manufacturers: Distribution by Company Size, Geographical Coverage and Type of Industry Served
Figure 5.1 Modular Cleanroom Providers: Distribution by Year of Establishment
Figure 5.2 Modular Cleanroom Providers: Distribution by Company Size
Figure 5.3 Modular Cleanroom Providers: Distribution by Location of Headquarters
Figure 5.4 Modular Cleanroom Providers: Distribution by Year of Establishment and Location of Headquarters
Figure 5.5 Modular Cleanroom Providers: Distribution by Company Size and Location of Headquarters
Figure 5.6 Modular Cleanroom Providers: Distribution by Type of Industry Served
Figure 5.7 Modular Cleanroom Providers: Distribution by Type of Industry Served and Location of Headquarters
Figure 5.8 Modular Cleanroom Providers: Distribution by Type of Modular Cleanroom Offered
Figure 5.9 Modular Cleanroom Providers: Distribution by Type of Industry Served and Type of Modular Cleanroom Offered
Figure 5.10 Modular Cleanroom Providers: Distribution by Type of Cleanroom Component Offered
Figure 5.11 Modular Cleanroom Providers: Distribution by Type of Industry Served and Cleanroom Component Offered
Figure 5.12 Modular Cleanroom Providers: Distribution by Type of Modular Cleanroom and Cleanroom Component Offered
Figure 5.13 Modular Cleanroom Providers: Distribution by Location of Headquarters, Type of Industry Served and Type of Modular Cleanroom Offered
Figure 5.14 Modular Cleanroom Providers: Distribution by Quality Certifications Obtained
Figure 6.1 Company Competitiveness Analysis: Benchmarking of Service Strength
Figure 6.2 Company Competitiveness Analysis: Benchmarking of Partnership Activity
Figure 6.3 Company Competitiveness Analysis: Small Companies
Figure 6.4 Company Competitiveness Analysis: Mid-sized Companies
Figure 6.5 Company Competitiveness Analysis: Large Companies
Figure 7.1 Cytiva: Stages of KUBio Facility Project
Figure 7.2 Germfree: Types of Lab Modules
Figure 7.3 IPM Technologies: Features of ISOdule Units
Figure 7.4 IPM Technologies: Applications of Modular Facilities
Figure 7.5 KeyPlants: Modular Facility-related Services
Figure 7.6 NNE: Modular Facility-related Services
Figure 7.7 NNE: Benefits of Bio on Demand Facility
Figure 7.8 Pharmadule: Modular Facility Services
Figure 7.9 Pharmadule: Process of Modular Facility Construction
Figure 8.1 Partnerships and Collaborations: Cumulative Year-wise Trend, 2012-2022
Figure 8.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 8.3 Partnerships and Collaborations: Distribution by Year of Partnership and Type of Partnership
Figure 8.4 Partnerships and Collaborations: Distribution by Type of Product
Figure 8.5 Partnerships and Collaborations: Distribution by Type of Partnership and Type of Product
Figure 8.6 Partnerships and Collaborations: Distribution by Type of Modular Facility
Figure 8.7 Partnerships and Collaborations: Distribution by Type of Product and Type of Modular Facility
Figure 8.8 Most Active Players: Distribution by Number of Partnerships
Figure 8.9 Partnerships and Collaborations: Distribution by Location of Partner’s Headquarters
Figure 8.10 Partnerships and Collaborations: Distribution by Location of Modular Facility
Figure 8.11 Partnerships and Collaborations: Distribution by Type of Partnership and Location of Modular Facility
Figure 8.12 Partnerships and Collaborations: Distribution by Type of Product and Location of Modular Facility
Figure 8.13 Intercontinental and Intracontinental Partnerships
Figure 8.14 Partnerships and Collaborations: Country-wise Distribution
Figure 9.1 Case Study on Modular Projects in Pharmaceutical and Biotechnology Industry: Modular versus Conventional Construction Methods
Figure 9.2 Modular and Conventional Facilities: Comparison of Construction Timelines
Figure 9.3 Case Study on Modular Projects in Pharmaceutical and Biotechnology Industry: KUBio Facility Construction Timeline
Figure 9.4 Case Study on Modular Projects in Pharmaceutical and Biotechnology Industry: Distribution by Type of Modular Facility
Figure 9.5 Case Study on Modular Projects in Pharmaceutical and Biotechnology Industry: Distribution by Size of Modular Facility
Figure 9.6 Most Active Manufacturers: Distribution by Number of Projects Delivered
Figure 9.7 Most Active Clients: Distribution by Number of Projects Received
Figure 9.8 Case Study on Modular Projects in Pharmaceutical and Biotechnology Industry: Distribution by Location of Modular Facility
Figure 9.9 Case Study on Modular Projects in Pharmaceutical and Biotechnology Industry: Distribution by Type of Facility and Size of Modular Facility
Figure 10.1 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Number of Facilities Delivered
Figure 10.2 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Type of Facility
Figure 10.3 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Purpose of Facility
Figure 10.4 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Type of Facility and Purpose of Facility
Figure 10.5 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Type of Investment
Figure 10.6 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Purpose of Facility and Type of Investment
Figure 10.7 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Size of Facility
Figure 10.8 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Type of Facility and Size of Facility
Figure 10.9 Facility Construction Trends in the Pharmaceutical Industry: Purpose of Facility and Size of Facility
Figure 10.10 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Location of Headquarters
Figure 10.11 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Location of Facility
Figure 10.12 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Type of Facility and Location of Facility
Figure 11.1 Cost, Time Optimization Framework: Impact of Type of Material
Figure 11.2 Cost, Time Optimization Framework: Impact of Type of Modular Construction
Figure 11.3 Cost, Time Optimization Framework: Impact of Purpose of Facility
Figure 11.4 Cost, Time Optimization Framework: Impact of Geographical Location
Figure 11.5 Integrated Outcome Modeling – Scenario Analysis
Figure 11.5 Integrated Outcome Modeling – Output Analysis
Figure 12.1 Global Modular Facilities Market in the Pharmaceutical / Biotechnology Sector, 2023-2035 (USD Million)
Figure 12.2 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Distribution by Size of Facility, 2023 and 2035
Figure 12.3 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Small Facilities, 2023-2035 (USD Million)
Figure 12.4 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Mid-sized Facilities, 2023-2035 (USD Million)
Figure 12.5 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Large Facilities, 2023-2035 (USD Million)
Figure 12.6 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Very Large Facilities, 2023-2035 (USD Million)
Figure 12.7 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Distribution by Type of Industry Served, 2023 and 2035
Figure 12.8 Modular Facilities Market in the Pharmaceutical Industry, 2023-2035 (USD Million)
Figure 12.9 Modular Facilities Market in the Biotechnology Industry, 2023-2035 (USD Million)
Figure 12.10 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Distribution by Type of Modular Construct, 2023 and 2035
Figure 12.11 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Hybrid Skid Modular Constructs, 2023-2035 (USD Million)
Figure 12.12 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Skid-Mounted Modular Constructs, 2023-2035 (USD Million)
Figure 12.13 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Plug-and-Play Modular Constructs, 2023-2035 (USD Million)
Figure 12.14 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Truckable Modular Constructs, 2023-2035 (USD Million)
Figure 12.15 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Other Modular Constructs, 2023-2035 (USD Million)
Figure 12.16 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Distribution by Type of Construction Component, 2023 and 2035
Figure 12.17 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Process Equipment, 2023-2035 (USD Million)
Figure 12.18 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Base Building, 2023-2035 (USD Million)
Figure 12.19 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Mechanical, Electrical and Plumbing System, 2023-2035 (USD Million)
Figure 12.20 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Process Commodities, 2023-2035 (USD Million)
Figure 12.21 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Other Construction Components, 2023-2035 (USD Million)
Figure 12.22 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Distribution by Purpose of Facility, 2023 and 2035
Figure 12.23 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Manufacturing Facilities, 2023-2035 (USD Million)
Figure 12.24 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Aseptic Filling Facilities, 2023-2035 (USD Million)
Figure 12.25 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Research and Development Facilities, 2023-2035 (USD Million)
Figure 12.26. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Other Facilities, 2023-2035 (USD Million)
Figure 12.27 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Distribution by Scale of Operation, 2023 and 2035
Figure 12.28 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Clinical Operations, 2023-2035 (USD Million)
Figure 12.29 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Commercial Operations, 2023-2035 (USD Million)
Figure 12.30 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Distribution by Type of Product, 2023 and 2035
Figure 12.31 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Cell and Gene Therapies, 2023-2035 (USD Million)
Figure 12.32 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Vaccines, 2023-2035 (USD Million)
Figure 12.33 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Biosimilars, 2023-2035 (USD Million)
Figure 12.34 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Monoclonal Antibodies, 2023-2035 (USD Million)
Figure 12.35 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Advanced Pharmaceuticals, 2023-2035 (USD Million)
Figure 12.36 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Sterile Products, 2023-2035 (USD Million)
Figure 12.37 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Viral Vectors, 2023-2035 (USD Million)
Figure 12.38 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Other Products, 2023-2035 (USD Million)
Figure 12.39 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Distribution by Type of Facility, 2023 and 2035
Figure 12.40 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for New Facilities, 2023-2035 (USD Million)
Figure 12.41 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Facility Expansions, 2023-2035 (USD Million)
Figure 12.42 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Planned Expansions, 2023-2035 (USD Million)
Figure 12.43 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Distribution by Type of Modular Construction, 2023 and 2035
Figure 12.44 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Relocatable Modular Construction, 2023-2035 (USD Million)
Figure 12.45 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Permanent Modular Construction, 2023-2035 (USD Million)
Figure 12.46 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Distribution by Type of Material Used, 2023 and 2035
Figure 12.47 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Steel, 2023-2035 (USD Million)
Figure 12.48 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Wood, 2023-2035 (USD Million)
Figure 12.49 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Concrete, 2023-2035 (USD Million)
Figure 12.50 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Distribution by Geography, 2023 and 2035
Figure 12.51 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector in North America, 2023-2035 (USD Million)
Figure 12.52 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector in Europe, 2023-2035 (USD Million)
Figure 12.53 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector in Asia, 2023-2035 (USD Million)
Figure 12.54 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector in Middle East and North Africa, 2023-2035 (USD Million)
Figure 12.55 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector in Rest of the World, 2023-2035 (USD Million)
Figure 14.1 Modular Facilities Market: Future Growth Opportunities
Figure 15.1 Concluding Remarks: Modular Facility Manufacturers Market Landscape
Figure 15.2 Concluding Remarks: Company Competitiveness Analysis
Figure 15.3 Concluding Remarks: Partnerships and Collaborations
Figure 15.4 Concluding Remarks: Case Study on Modular Projects in Pharmaceutical and Biotechnology Industry
Figure 15.5 Concluding Remarks: Facility Construction Trends in Pharmaceutical Industry
Figure 15.6 Concluding Remarks: Market Forecast

List Of Tables

Table 3.1 Cleanroom Classification Standards
Table 3.2 ISO and FED STD 209E: Cleanroom Classification
Table 4.1 Modular Facility Manufacturers: List of Service Providers
Table 4.2 Modular Facility Manufacturers: Information on Type of Industry Served, GMP Compliance and Geographical Coverage
Table 4.3 Modular Facility Manufacturers: Information on Type of Modular Construction and Type of Material Used
Table 4.4 Modular Facility Manufacturers: List of Quality Certifications Obtained
Table 5.1 Modular Cleanroom Providers: List of Companies
Table 5.2 Modular Cleanroom Providers: Type of Industry Served
Table 5.3 Modular Cleanroom Providers: Type of Modular Cleanroom Offered
Table 5.4 Modular Cleanroom Providers: Type of Cleanroom Component Offered
Table 5.5 Modular Cleanroom Providers: List of Regulatory Approvals and Certifications Obtained
Table 6.1 Company Competitiveness Analysis: Benchmarking of Service Strength
Table 6.2 Company Competitiveness Analysis: Benchmarking of Partnership Activity
Table 6.3 Company Competitiveness Analysis: List of Small players
Table 6.4 Company Competitiveness Analysis: List of Mid-sized players
Table 6.5 Company Competitiveness Analysis: List of Large players
Table 7.1 List of Companies Profiled
Table 7.2 Cytiva: Key Highlights
Table 7.3 Cytiva: Modular Facility-Related Services
Table 7.4 Cytiva: Single-Use Technology Portfolio
Table 7.5 Cytiva: Modular Projects
Table 7.6 Cytiva: Recent Developments and Future Outlook
Table 7.7 G-Con Manufacturing: Key Highlights
Table 7.8 G-Con Manufacturing: Modular Facility-Related Services
Table 7.9 G-Con Manufacturing: Modular Projects
Table 7.10 G-Con Manufacturing: Recent Developments and Future Outlook
Table 7.11 Germfree: Key Highlights
Table 7.12 Germfree: Modular Facility-Related Services
Table 7.13 Germfree: Key Features of Modules
Table 7.14 Germfree: Recent Developments and Future Outlook
Table 7.15 IPM Technologies: Key Highlights
Table 7.16 IPM Technologies: Types of Modular Production Units
Table 7.17 KeyPlants: Key Highlights
Table 7.18 KeyPlants: Recent Developments and Future Outlook
Table 7.19 ModuleCo Pharma: Key Highlights
Table 7.20 ModuleCo Pharma: Key Features of Modular Facilities
Table 7.21 NNE: Key Highlights
Table 7.22 NNE: Modular Projects
Table 7.23 NNE: Recent Developments and Future Outlook
Table 7.24 Pharmadule: Key Highlights
Table 7.25 Pharmadule: Modular Projects
Table 7.26 Pharmadule: Recent Developments and Future Outlook
Table 8.1 Modular Facility Manufacturers: List of Partnerships and Collaborations, 2012-2022
Table 8.2 Modular Facility Manufacturers: List of Partnerships and Collaborations, Information on Type of Agreement 2012-2022
Table 9.1 Modular Facilities and Conventional Facilities: Comparison of Construction Investment and Financial Returns
Table 9.2 Modular Facilities: List of Modular Projects
Table 9.3 Modular Facilities: List of Clients and Location of Facility
Table 10.1 Conventional Facilities: Facility Construction Projects Undertaken in the Pharmaceutical / Biotechnology Industry (Top 20 Companies): Historical Data, January 2016-2022
Table 10.2 Conventional Facilities: Information on Location of Headquarters, Area of Facility and Size of Facility
Table 13.1 Modular Facilities: Technological Advancements
Table 16.1 Avon Modular: Company Snapshot
Table 16.2. Environmental Systems Corporation: Company Snapshot
Table 16.3 Exyte: Company Snapshot
Table 16.4 G-Con Manufacturing: Company Snapshot
Table 16.5 Modular Devices: Company Snapshot
Table 16.6 ModWave: Company Snapshot
Table 16.7 Subzero Simplex Cleanrooms: Company Snapshot
Table 16.8 Vernick Cleanroom Design and Construction: Company Snapshot
Table 16.9 Zeton: Company Snapshot
Table 17.1 Modular Facility Manufacturers: Distribution by Year of Establishment
Table 17.2 Modular Facility Manufacturers: Distribution by Company Size
Table 17.3 Modular Facility Manufacturers: Distribution by Location of Headquarters (Region-wise)
Table 17.4 Modular Facility Manufacturers: Distribution by Location of Headquarters (Country-wise)
Table 17.5 Modular Facility Manufacturers: Distribution by Year of Establishment and Location of Headquarters
Table 17.6 Modular Facility Manufacturers: Distribution by Company Size and Location of Headquarters
Table 17.7 Modular Facility Manufacturers: Distribution by Type of Industry Served
Table 17.8 Modular Facility Manufacturers: Distribution by Geographical Coverage
Table 17.9 Modular Facility Manufacturers: Distribution by Type of Industry Served and Geographical Coverage
Table 17.10 Modular Facility Manufacturers: Distribution by GMP Compliance
Table 17.11 Modular Facility Manufacturers: Distribution by Geographical Coverage and GMP Compliance
Table 17.12 Modular Facility Manufacturers: Distribution by Type of Modular Construction
Table 17.13 Modular Facility Manufacturers: Distribution by Type of Industry Served and Type of Modular Construction
Table 17.14 Modular Facility Manufacturers: Distribution by Type of Material Used
Table 17.15 Modular Facility Manufacturers: Distribution by Type of Modular Construction and Type of Material Used
Table 17.16 Modular Facility Manufacturers: Distribution by Company Size, Geographical Coverage and Type of Industry Served
Table 17.17 Modular Cleanroom Providers: Distribution by Year of Establishment
Table 17.18 Modular Cleanroom Providers: Distribution by Company Size
Table 17.19 Modular Cleanroom Providers: Distribution by Location of Headquarters (Region-wise)
Table 17.20 Modular Cleanroom Providers: Distribution by Location of Headquarters (Country-wise)
Table 17.21 Modular Cleanroom Providers: Distribution by Year of Establishment and Location of Headquarters
Table 17.22 Modular Cleanroom Providers: Distribution by Company Size and Location of Headquarters
Table 17.23 Modular Cleanroom Providers: Distribution by Type of Industry Served
Table 17.24 Modular Cleanroom Providers: Distribution by Type of Industry Served and Location of Headquarters
Table 17.25 Modular Cleanroom Providers: Distribution by Type of Modular Cleanroom Offered
Table 17.26 Modular Cleanroom Providers: Distribution by Type of Industry Served and Type of Modular Cleanroom Offered
Table 17.27 Modular Cleanroom Providers: Distribution by Type of Cleanroom Component Offered
Table 17.28 Modular Cleanroom Providers: Distribution by Type of Industry Served and Cleanroom Component Offered
Table 17.29 Modular Cleanroom Providers: Distribution by Type of Modular Cleanroom and Cleanroom Component Offered
Table 17.30 Modular Cleanroom Providers: Distribution by Location of Headquarters, Type of Industry Served and Type of Modular Cleanroom Offered
Table 17.31 Modular Cleanroom Providers: Distribution by Quality Certifications Obtained
Table 17.32 Partnerships and Collaborations: Cumulative Year-wise Trend, 2012-2022
Table 17.33 Partnerships and Collaborations: Distribution by Type of Partnership
Table 17.34 Partnerships and Collaborations: Distribution by Year of Partnership and Type of Partnership
Table 17.35 Partnerships and Collaborations: Distribution by Type of Product
Table 17.36 Partnerships and Collaborations: Distribution by Type of Partnership and Type of Product
Table 17.37 Partnerships and Collaborations: Distribution by Type of Modular Facility
Table 17.38 Partnerships and Collaborations: Distribution by Type of Product and Type of Modular Facility
Table 17.39 Most Active Players: Distribution by Number of Partnerships
Table 17.40 Partnerships and Collaborations: Distribution by Location of Partner’s Headquarters
Table 17.41 Partnerships and Collaborations: Distribution by Location of Modular Facility
Table 17.42 Partnerships and Collaborations: Distribution by Type of Partnership and Location of Modular Facility
Table 17.43 Partnerships and Collaborations: Distribution by Type of Product and Location of Modular Facility
Table 17.44 Partnerships and Collaborations: Intercontinental and Intracontinental Distribution
Table 17.45 Partnerships and Collaborations: Location of Headquarters (Country-wise) Distribution
Table 17.46 Modular Facilities: Distribution by Type of Modular Facility
Table 17.47 Modular Facilities: Distribution by Size of Facility
Table 17.48 Most Active Manufacturers: Distribution by Number of Projects Delivered
Table 17.49 Most Active Clients: Distribution by Number of Projects Received
Table 17.50 Modular Facilities: Distribution by Location of Modular Facility
Table 17.51 Modular Facilities: Distribution by Type of Facility and Size of Modular Facility
Table 17.52 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Number of Facilities Delivered
Table 17.53 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Type of Facility
Table 17.54 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Purpose of Facility
Table 17.55 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Type of Facility and Purpose of Facility
Table 17.56 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Type of Investment
Table 17.57 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Purpose of Facility and Type of Investment
Table 17.58 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Size of Facility
Table 17.59 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Type of Facility and Size of Facility
Table 17.60 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Purpose of Facility and Size of Facility
Table 17.61 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Location of Headquarters
Table 17.62 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Location of Facility
Table 17.63 Facility Construction Trends in the Pharmaceutical Industry: Distribution by Type of Facility and Location of Facility
Table 17.64 Global Modular Facilities Market in the Pharmaceutical / Biotechnology Sector, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 17.65 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Distribution by Size of Facility, 2023 and 2035
Table 17.66 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Small Facilities, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.67 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Mid-sized Facilities, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.68 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Large Facilities, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.69 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Very Large Facilities, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.70 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Distribution by Type of Industry Served, 2023 and 2035
Table 17.71 Modular Facilities Market in the Pharmaceutical Industry, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.72 Modular Facilities Market in the Biotechnology Industry, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.73 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Distribution by Type of Modular Construct, 2023 and 2035
Table 17.74 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Hybrid Skid Modular Constructs, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.75 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Skid-Mounted Modular Constructs, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.76 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Plug-and-Play Modular Constructs, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.77 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Truckable Modular Constructs, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.78 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Other Modular Constructs, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.79 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Distribution by Type of Construction Component, 2023 and 2035
Table 17.80 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Process Equipment, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.81 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Base Building, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.82 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Mechanical, Electrical and Plumbing System, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.83 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Process Commodities, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.84 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Other Construction Components, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.85 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Distribution by Purpose of Facility, 2023 and 2035
Table 17.86 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Manufacturing Facilities, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.87 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Aseptic Filling Facilities, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.88 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Research and Development Facilities, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.89 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Other Facilities, 2023-2035, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.90 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Distribution by Scale of Operation, 2023 and 2035
Table 17.91 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Clinical Operations, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.92 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Commercial Operations, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.93 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Distribution by Type of Product, 2023 and 2035
Table 17.94 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Cell and Gene Therapies, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.95 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Vaccines, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.96 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Biosimilars, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.97 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Monoclonal Antibodies, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.98 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Advanced Pharmaceuticals, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.99 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Sterile Products, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.100 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Viral Vectors, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.101 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Other Products, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.102 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Distribution by Type of Expansion, 2023 and 2035
Table 17.103 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for New Facilities, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.104 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Facility Expansions, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.105 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Planned Expansions, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.106 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Distribution by Type of Modular Construction, 2023 and 2035
Table 17.107 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Relocatable Modular Construction, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.108 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Permanent Modular Construction, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.109 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Distribution by Type of Material Used, 2023 and 2035
Table 17.110 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Steel, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.111 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Wood, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.112 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Concrete, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.113 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Distribution by Geography, 2023 and 2035
Table 17.114 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector in North America, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.115 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector in Europe, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.116 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector in Asia, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.117 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector in Middle East and North Africa, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.118 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector in Rest of the World, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)

List Of Companies

The following companies and organizations have been mentioned in the report:

  1. 209Technologies
  2. 3P Biopharmaceuticals
  3. A.D. Clean Rooms
  4. Ab Biotechnology
  5. Abbott
  6. AbbVie
  7. ABN Cleanroom Technology
  8. Abtech
  9. Abzena
  10. ACH Engineering
  11. ACIC Machinery
  12. ACME Cleanroom Technologies
  13. Acumen Technology
  14. Adamson Pharma
  15. ADC Biotechnology
  16. ADK Modulraum
  17. AdvanceTEC
  18. AES Clean Technology
  19. Air Micron Cleantech
  20. Aircare Projects
  21. Airgas
  22. AirKey
  23. Airology
  24. Airplan
  25. Airtech Systems
  26. Ajinomoto
  27. Albian Group
  28. Alfa PEB
  29. Allied Cleanrooms
  30. AM Technical Solutions
  31. American Cleanroom Systems
  32. Amgen
  33. Amicron Cleantech
  34. Amperox 
  35. Angstrom Technology
  36. Anker Projects
  37. APsystems
  38. Aprotech
  39. Ardmac
  40. Asgard Cleanroom Solutions
  41. AstraZeneca
  42. Atmos Tech Industries
  43. Autolus Therapeutics
  44. AveXis
  45. Avid Bioservices
  46. Avon Modular
  47. AWS Bio-Pharma Technologies
  48. Axenic Systems
  49. B. Braun Medical
  50. Balaji CleanAir Solutions
  51. Bangalore Air Tech Solution
  52. Bassaire
  53. Baxter
  54. Bayer
  55. BC Technology
  56. BeiGene
  57. Belcher Equipment
  58. bioBUBBLE
  59. Biocatalysts
  60. Bio Clean Integrated Air System
  61. BioCon Solutions
  62. Biofactory Competence Center
  63. Biogen
  64. Biologics Modular
  65. BM Engineering
  66. Bode Equipment
  67. Boehringer Ingelheim
  68. BOXX Modular
  69. Brammer Bio
  70. Bristol Myers Squibb
  71. Build It
  72. Butler Manufacturing
  73. Calitech Technical Services
  74. Cambridge Cleanroom
  75. Can-Trol Environmental
  76. Caron
  77. C-Cube
  78. CE Group
  79. CGT Catapult Stevenage
  80. Chemgineering
  81. Chempharm
  82. Chrisleen Cleanroom Projects
  83. CoCID Associates
  84. Cipharm
  85. Clean Air Flow
  86. Clean Air Products
  87. Clean Air Systems
  88. Clean Air Technology
  89. Clean3 Modular Cleanroom Systems
  90. Clean Modules
  91. Clean Room Depot
  92. Clean Rooms International
  93. Clean Rooms Plus
  94. Clean Rooms West
  95. Clean Zone Technology
  96. CleanAir Solutions
  97. Cleanetics
  98. Cleanroom Ceiling Systems
  99. Cleanroom Combination Group
  100. Cleanroom Equipment
  101. Cleanroom Solutions
  102. Cleanroom Synergy
  103. Cleanrooms Australia
  104. Cleanrooms By United
  105. Cleanrooms Containments
  106. Cleanrooms Plus
  107. CleanSpace
  108. CleanZones
  109. ClearSphere
  110. Clenviron Technologies
  111. Clestra Hauserman
  112. Clestra Cleanroom
  113. Codiak BioSciences
  114. Commercial Structures corporation
  115. Connect 2 Cleanrooms 
  116. CONSAB International
  117. Cotaplan
  118. CRB
  119. CRDB Modular Cleanroom Solutions
  120. Creative Foam
  121. Cytiva
  122. CytoImmune Therapeutics
  123. Dagard
  124. Daldrop
  125. Dawson Group
  126. Dec Group
  127. Design Filtration Microzone
  128. Dexcom
  129. Dozie and Dozie’s Pharma
  130. DPR Construction
  131. Drees & Sommer
  132. E- Pack Polymers
  133. Ebtech Industrial Modular Building Solutions
  134. Eli Lilly
  135. Emergent BioSolutions
  136. Enbloc
  137. Envair Electrodyne
  138. Environmental Systems Corporation
  139. Envision Biotech
  140. EPACK Prefab
  141. Erytech Pharma
  142. ESS Modular
  143. Everest Composites
  144. Expression Therapeutics
  145. Extract Technology
  146. Exyte
  147. Fabtech
  148. Ferring Pharnmaceuticals
  149. Filtration Technology
  150. Firmament Technology
  151. Firs Bioengineering
  152. Florida Cleanroom Systems
  153. Flowstar Corporation
  154. Fluor
  155. FOSELEV
  156. Galderma
  157. Gallant Technologies
  158. G-Con Manufacturing
  159. GenCure
  160. Genentech
  161. Gerbig Engineering Company
  162. Germfree
  163. Gilead Sciences
  164. GlaxoSmithKline
  165. GMP Technical Solutions
  166. GMPMax Pharma
  167. Green Carrier Consultancy and Tech Solutions
  168. GreenTech Venture
  169. Grekon Infratech
  170. Grifols
  171. GSK
  172. Guardtech Cleanrooms
  173. Halco Products
  174. HAZE comfort
  175. Hectra Enviro Systems
  176. Hemair Systems
  177. HEMCO
  178. HEPAire Products
  179. Hermetel Oy
  180. Hexakore
  181. Hodess Construction
  182. HOK
  183. Holden
  184. Hume Group MC
  185. Huntair
  186. Iberconcept
  187. ICT Innovative Cleanroom Technologies
  188. Iguna Pharmaceutical Technologies
  189. Ingelyt
  190. Innovation Expert Cleanrooms
  191. Innovative Cleanroom Technologies
  192. Innovative Pharmaintech
  193. Innovators Cleantech
  194. Instant Cleanroom Solutions
  195. Instaspace
  196. Instituto Butantan
  197. Intact
  198. Integrated Cleanroom Technologies
  199. Integrity Cleanroom
  200. IPM Technologies
  201. IPS
  202. IsoTech Design
  203. Jacobs        
  204. JHL Biotech
  205. Johnson & Johnson
  206. Just Biotherapeutics
  207. Just-Evotec Biologics
  208. KABTech Corporation
  209. Kaizen Airtech Solutions
  210. Karlsruhe Institute of Technology
  211. KELVIN
  212. KeyPlants
  213. Kingspan
  214. Kleanzone Systems
  215. Klimapharm Technologies
  216. KTEC Cleanroom Systems
  217. L7 Informatics
  218. Lab in Boxes
  219. Labover
  220. LabRum
  221. Labworks International
  222. Lacy Construction
  223. Lasco Services
  224. Lennox Clean Air Technologies
  225. Libbs Farmacêutica
  226. Liberty Industries
  227. LifeAire Systems
  228. Lindner
  229. Linesight
  230. LM Air Technology
  231. Longden Company
  232. Lonza
  233. LSB La Salle Blanche
  234. MAK Clean Air Systems
  235. Marion VA Medical Center
  236. Mars Sterile Solutions
  237. McLennan & Company
  238. M. Davis & Sons
  239. MDI
  240. MECART
  241. Medical Air Technology
  242. Merck
  243. Merit Holdings
  244. Microbinc
  245. MicroCool
  246. MobileLabCompany
  247. Modubuild
  248. Moduguard
  249. Modular Cleanrooms
  250. Modular Devices
  251. Modular Panel Systems
  252. ModuleCo Pharma
  253. Modulus Cleanrooms
  254. Monmouth Scientific
  255. MRC Cleanrooms
  256. MRC Systems
  257. MTX Contracts
  258. Nano Clean
  259. National Cancer Institute
  260. National Institutes of Health
  261. National Partitions
  262. NCI Clean 
  263. NGS Cleanroom Solutions
  264. Nicomac
  265. NNE
  266. Norwood Group
  267. Novartis
  268. Novo Nordisk
  269. OCTANORM
  270. Octapharma
  271. Ori Biotech
  272. Ortner Cleanrooms Unlimited
  273. Oxford BioMedica
  274. Pacific Environmental Technologies
  275. Pall Biotech
  276. Panel Built
  277. Panelco
  278. WSP
  279. Parteco
  280. PCCA
  281. Pentec Health
  282. Perotech Sciences
  283. Pfizer
  284. Pharma Access
  285. Pharma Air Control Engineers
  286. Pharma Air Modular Systems
  287. Pharmacon
  288. Pharmadule
  289. Pharmaintech Turnkey Solutions
  290. Piramal Pharma Solutions
  291. Plascore
  292. PortaFab
  293. Porta-King Building Systems
  294. Power And Motion
  295. PPG Cleanrooms
  296. Precise Engineering 
  297. Precision Air Technology
  298. Precision Cleanrooms
  299. Precision Extraction Solutions
  300. ProCleanroom
  301. Propart Modular
  302. ProPharma Cleanrooms
  303. Protech Solutions
  304. Puracore
  305. PureLinc Cleanrooms
  306. Purever Tech
  307. QleanAir Scandinavia
  308. Riddhi Metals
  309. Rinac
  310. Ritterwand
  311. Robert Soper
  312. Roche
  313. Rubius Therapeutics
  314. Saakvee Technologies
  315. Sai Seva Service
  316. Sam Air Solution
  317. Sanofi
  318. Sapphire Cleanrooms
  319. Saudi Bio
  320. Schering Plough
  321. Schilling Engineering
  322. SciMed
  323. SD Consulting
  324. SGS
  325. Shanghai HJ Modular Cleanroom
  326. Shanghai Junshi Biosciences
  327. SIC Experts
  328. Siemens
  329. Simplex Isolation Systems
  330. Skanska
  331. Skylark Engineering Technologies
  332. SML Clean Room Solutions
  333. SP Groups
  334. Span Construction and Engineering
  335. Speed Space
  336. Srprefabs Modular Cleanroom
  337. Starrco
  338. Stefatos
  339. Steriltech
  340. STERIS Life Sciences
  341. Stodec Products
  342. Stragen Pharma
  343. Strike Bio
  344. Subzero Engineering
  345. Swedish Modules
  346. Syntec Airflow System
  347. System Integration Technology
  348. Systems BD
  349. SZ Airkey Environmental Tech & Eng
  350. Taiyo Pharma Tech
  351. Takeda
  352. Technical Air Products
  353. Telstar Life Science Solutions
  354. Terra Universal
  355. Zhejiang Teruisi Pharmaceutical
  356. TEVA Pharmceutical
  357. The Softwall Shop
  358. Thrius Pharma Expertize
  359. Total Precision Cleanrooms Aust
  360. Touchlight
  361. Travis CleanAir
  362. CTriumph Modular
  363. TrueBinding
  364. Tudela International
  365. Ultrapure Technology
  366. Unibio
  367. UNIFIED Technical Solutions
  368. Unikelvin Ventures
  369. United Partition Systems
  370. Univercells
  371. Universal Technical Solutions
  372. University of Tennessee Health Science Center
  373. Unizima
  374. Vanrx Pharmasystems
  375. Vedaa Prefab Technologies
  376. Veltek Associates
  377. Vernick
  378. Viessmann Technologies
  379. Vitma Positech
  380. VK Clean Rooms
  381. VRP Cleanroom Systems
  382. W.W. Cannon
  383. Wacker Chemie
  384. Walvax
  385. Weaver Technologies
  386. Westbury Cleanrooms
  387. Western Environmental Corporation
  388. Whitenair Technologies
  389. WHP Engineering
  390. WuXi Vaccines
  391. Xytel
  392. YRS Enterprise
  393. Zeton
  394. Ziccum

Source 1: https://www.sciencedirect.com/topics/engineering/modular-construction
Source 2: https://www.pall.co.in/en/biotech/blog/modular-biomanufacturing.html
Press Release: https://www.rootsanalysis.com/press-releases/132-modular-facilities-flexible-drug-manufacturing-platforms-of-the-future-.html

PRICING DETAILS

USD 5,899

This license grants the right of use of the purchased report to a single recipient only (normally the person who buys the report). You may access the material on your computer, as and when required, for your own personal use. You may also print read more

This license grants the right of use of the purchased report by the employees of a business unit at a particular site/office location. The report may be accessed on the computer of any employee within the business unit. You may also print multiple read more

This license grants the right of use of the purchased report by a department / team of individuals (up to 12) in a particular organization. The license does not limit the use to a particular site / office location. The report may be accessed on the computer read more

This license entitles the buyer of the report to share, distribute the report (either full or in part) with other employees of the same firm/enterprise. The report may be accessed by any employee of the enterprise and there is no limit on the read more

Discounts available for multiple report purchases
sales@rootsanalysis.com

This site uses cookies for better browsing experience  Accept

Copyright © 2023 Roots Analysis. All Rights Reserved.